Tool Helps Clinicians Determine When Tests Are Needed for Chest Pain
An online tool can accurately predict which patients with chest pain are likely to have normal non-invasive test results and remain free of cardiac adverse events.
An online tool can accurately predict which patients with chest pain are likely to have normal non-invasive test results and remain free of cardiac adverse events.
Angionetics has announced that its Phase 3 clinical investigation of Generx (Ad5FGF-4) has been granted Fast Track status by the Food and Drug Administration (FDA).
One lot of Actavis’ Nifedipine 10mg capsules is being recalled after a pharmacist reported finding a Procardia capsule in the bottle.
Development of depression post-diagnosis tied to increased morbidity, mortality
Consistent reduction in composite of death, MI, ischemia-driven revascularization, stent thrombosis
Espero announced the launch of GoNitro (nitroglycerin) sublingual powder for acute relief of an attack or prophylaxis of angina pectoris due to coronary artery disease.
Aralez announced that the Food and Drug Administration (FDA) has approved Yosprala (omeprazole and aspirin) to treat patients who require aspirin for secondary prevention of cardiovascular (CV) and cerebrovascular events and who are at risk of developing aspirin-associated gastric ulcers.
Dr. Reddy’s announced the launch of Nitroglycerin sublingual tablets, the generic version of Pfizer’s Nitrostat.
Espero announced that the Food and Drug Administration (FDA) has approved GoNitro (nitroglycerin) sublingual powder for acute relief of an attack or prophylaxis of angina pectoris due to coronary artery disease.
Mylan announced the launch of Metoprolol Tartrate Tablets in new 37.5mg and 75mg strengths, the generic version of Novartis’ Lopressor.